Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,708 public trials 1,048 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)

NCT06555861

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ICO Nantes, Saint Herblain, France
  • CHRU de Brest Brest, France
  • Centre Eugènes Marquis Rennes, France
  • CHU de Tours Tours, France
View Trial Details
Completed

Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)

NCT04529564

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • National Taiwan University Hospital-Hsinchu Branch Hsinchu, Taiwan
  • Chang Gung Medical Foundation-Kaohsiung Branch Kaohsiung City, Taiwan
  • Chang Gung Medical Foundation-Keelung Branch Keelung, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Completed

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

NCT01970865

Conditions
ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Highlands Oncology Group/Research Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Irvine Medical Center Orange, California, United States
View all 77 locations
View Trial Details
Completed

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866

Conditions
AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)

NCT02679170

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital Clínico Univ. de Santiago de Compostela Santiago de Compostela, A Coruña, Spain
  • Hospital Virgen de los Lirios Alcoy, Alicante, Spain
  • Complejo Hospitalario de Jerez Jerez de la Frontera, Cadiz, Spain
  • Hospital Marqués de Valdecilla Santander, Cantabria, Spain
View all 32 locations
View Trial Details
Completed

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

NCT05068427

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Southern Medical University Affiliated Nanfang Hospital Guangzhou, Guangdong, China
  • Guangxi Medical University Affiliated Tumor Hospital Nanning, Guangxi, China
View Trial Details

Related conditions